19626-36-9

Basic information

• Product Name: methyl 2-(3-bromo-4-methoxyphenyl)acetate
• Synonyms: methyl 2-(3-bromo-4-methoxyphenyl)acetate
• CAS NO: 19626-36-9
• Molecular Weight: 259.1
• Mol File: 19626-36-9.mol
• Article Data: 20

Chemical Properties

• CAS DataBase Reference: methyl 2-(3-bromo-4-methoxyphenyl)acetate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 2-(3-bromo-4-methoxyphenyl)acetate(19626-36-9)
• EPA Substance Registry System: methyl 2-(3-bromo-4-methoxyphenyl)acetate(19626-36-9)

Safety Data

• Hazardous Substances Data: 19626-36-9(Hazardous Substances Data)

Upstream product

• 156-38-7 4-hydroxyphenylacetate 
• 38692-80-7 2-(3-bromo-4-hydroxyphenyl)acetic acid 
• 104-01-8 4-Methoxyphenylacetic acid 
• 34918-57-5 methyl 3-bromo-4-hydroxyphenylacetate 
• 74-88-4 methyl iodide 
• 774-81-2 (3-bromo-4-methoxy-phenyl)-acetic acid 
• 77-78-1 dimethyl sulfate 
• 23786-14-3 4-methoxy-phenyl acetic acid methyl ester 
• 67-56-1 methanol 

Downstream Products

• 131602-96-5 2-(3-Bromo-4-methoxy-phenyl)-4H-benzo[1,4]thiazin-3-one 
• 137-07-5 2-amino-benzenethiol 
• 16010-89-2 3-<4-Carboxy-methyl-phenoxy>-4-methoxy-phenylessigsaeure-methylester 
• 1233354-79-4 C₁₁H₁₃BrO₃ 
• 1422431-63-7 14-(R)-9-benzyloxy-2,3,10-trimethoxytetrahydroprotoberberine 
• 1422431-64-8 14-(S)-9-benzyloxy-2,3-methylenedioxy-10-methoxytetrahyrdooxyprotoberberine 
• 1429118-98-8 14-(R)-9-benzyloxy-2,3-methylenedioxy-10-methoxytetrahyrdooxyprotoberberine 
• 107538-88-5 14-(S)-3,9-dibenzyloxy-2,10-dimethoxytetrahydroprotoberberine 
• 107538-86-3 14-(R)-3,9-dibenzyloxy-2,10-dimethoxytetrahydroprotoberberine 
• 1422431-65-9 14-(S)-3,9-dibenzyloxy-2,10-dimethoxytetrahydroprotoberberine 
• 1422431-66-0 14-(R)-3,9-dibenzyloxy-2,10-dimethoxytetrahydroprotoberberine 
• 6487-33-8 (-)-isocorypalmine 
• 572-76-9 tetrahydroberberrubine 
• 572-76-9 5,6,13,14-tetrahydro-9-hydroxy-10-methoxy-2,3-(methylenedioxy)-8H-dibenzo[a,g]quinolizine 

Relevant articles and documents

COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING NASH, NAFLD, AND OBESITY

The present technology relates to methods of treating NASH, NAFLD and/or obesity using compounds of Formulas I, II, III, IV, V, and/or VI. The methods include administering to a subject suffering from one or more of non-alcoholic steatohepatitis (NASH), non- alcoholic fatty liver disease (NAFLD) and/or obesity a therapeutically effective amount of such a compound

ALDOSTERONE SYNTHASE INHIBITORS

The present invention relates to compounds of formula I: and pharmaceutically acceptable salts thereof, wherein X, R1, R2 and R3 are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.

NOVEL DIHYDROQUINOLIZINONES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION

The invention provides novel compounds having the general formula (I) wherein R1, R2 R3, R4, R5 and R6 are as described herein, compositions including the compounds and methods of using the compounds in the treatment of the hepatitis B virus.